Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Patients with Endometrial Cancer in the SGO Clinical Outcomes Registry
Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infecti...
Saved in:
Published in | Annals of surgical oncology Vol. 32; no. 5; pp. 3458 - 3464 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.05.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.
Patients and Methods
We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables.
Results
A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%;
P
= 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all
P
< 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all
P
< 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (
P
< 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (
P
< 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.
Conclusions
The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management. |
---|---|
AbstractList | Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.
We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables.
A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.
The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management. Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC. Patients and Methods We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables. Results A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open ( P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion ( P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent. Conclusions The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management. BackgroundEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.Patients and MethodsWe queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables.ResultsA total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.ConclusionsThe adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management. Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.BACKGROUNDEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables.PATIENTS AND METHODSWe queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables.A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.RESULTSA total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.CONCLUSIONSThe adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management. |
Author | Chefetz, IIana Ngo, Julie Straughn, J. Michael Mize, Benjamin Abdel-Gadir, Deena Lachance, Jenny Yousif, Abdelrahman Timmins, Patrick Dewdney, Summer Lachance, Jason Rocconi, Rodney P. |
Author_xml | – sequence: 1 givenname: Abdelrahman surname: Yousif fullname: Yousif, Abdelrahman email: abdelrahman.yousif@ttuhsc.edu organization: OBGYN Department, Texas Tech University Health Sciences Center – sequence: 2 givenname: Julie surname: Ngo fullname: Ngo, Julie organization: Henry Ford Hospital Family Medicine Residency – sequence: 3 givenname: Deena surname: Abdel-Gadir fullname: Abdel-Gadir, Deena organization: College of Human Medicine, Michigan State University – sequence: 4 givenname: Rodney P. surname: Rocconi fullname: Rocconi, Rodney P. organization: University of Mississippi Medical Center – sequence: 5 givenname: Patrick surname: Timmins fullname: Timmins, Patrick organization: Women’s Cancer Care Associates – sequence: 6 givenname: Jason surname: Lachance fullname: Lachance, Jason organization: Maine Health – sequence: 7 givenname: J. Michael surname: Straughn fullname: Straughn, J. Michael organization: University of Alabama at Birmingham – sequence: 8 givenname: Summer surname: Dewdney fullname: Dewdney, Summer organization: Rush University Medical Center – sequence: 9 givenname: Jenny surname: Lachance fullname: Lachance, Jenny organization: Research Department, Hurley Medical Center, Michigan State University – sequence: 10 givenname: Benjamin surname: Mize fullname: Mize, Benjamin organization: Department of Gynecologic Oncology, Karmanos Cancer Institute, Wayne State University – sequence: 11 givenname: IIana surname: Chefetz fullname: Chefetz, IIana email: chefetz_i@mercer.edu organization: Department of Biomedical Sciences, Mercer University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39982547$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksluFDEQhlsoiCzwAhyQJS5cGrx3-4RGoxAiBQ1iOVtuT_WMo257sN2D-jl4YTyZEJYDJ1uu7_-rXFXn1YkPHqrqOcGvCeXiTSKYM15jKmoiFVf1_Kg6I6I8cdmSk3LHsq0VleK0Ok_pFmPSMCyeVKdMqZYK3pxVP5bB7yEmFzzqYxjRB-fdaIZhRtd-b5LbA_o8xY2zZkCL3S4GY7eQUA5otQN_F4M4o8UY_AZ9NNmBzwl9d3mLLv06jJCjK9Kl8RYich7lbXG8WqHlUDIdXFdTtoVL6BNsXMpxflo97s2Q4Nn9eVF9fXf5Zfm-vlldXS8XN7XlVOZa2F40qmulYL2ilkO3lh0nnDOC1xY4oZL2IJsGOkUxGGUYWLUurSFrAZ1gF9Xbo-9u6kYoEp-jGfQulgbEWQfj9N8R77Z6E_aaENVIxnFxeHXvEMO3CVLWo0sWhsF4CFPSrMyFtISpQ7KX_6C3YYq-_K9QrVKSNowX6sWfJT3U8mtgBaBHwMaQUoT-ASFYH7ZCH7dCl63Qd1uh5yJiR1EqsC_z-p37P6qfzku9Vg |
Cites_doi | 10.1001/jama.2017.2068 10.1016/j.ajog.2019.05.004 10.1016/j.ejso.2019.11.519 10.1016/j.ygyno.2022.06.004 10.1007/s00404-019-05393-5 10.1016/j.clon.2021.05.001 10.7150/ijms.52293 10.1200/JCO.2009.22.3248 10.1007/s10147-020-01744-4 10.1016/j.ygyno.2018.01.021 10.1097/IGC.0000000000000594 10.1016/j.ygyno.2014.06.008 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Springer Nature B.V. May 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. May 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO H94 K9. 7X8 5PM |
DOI | 10.1245/s10434-025-16949-y |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1534-4681 |
EndPage | 3464 |
ExternalDocumentID | PMC11976340 39982547 10_1245_s10434_025_16949_y |
Genre | Journal Article |
GroupedDBID | --- -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 203 23M 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2WC 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDZB AFEXP AFJLC AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AYFIA AZFZN B-. BA0 BAWUL BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C1A C6C CAG CCPQU COF CS3 CSCUP DDRTE DIK DL5 DNIVK DPUIP E3Z EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HEOXT HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD OWW P19 P2P P9S PF0 PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOQ YFH YLTOR Z45 ZMTXR ZOVNA AAYXX ABFSG ACMFV ACSTC AEZWR AFHIU AFOHR AHWEU AIXLP ATHPR CITATION PHGZM CGR CUY CVF ECM EIF NPM 7TO ABRTQ H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c426t-5cf579b8653f92c4ebd6b4144310dce41262fe677eb920ea9a3ec9d6811d5eb53 |
IEDL.DBID | C6C |
ISSN | 1068-9265 1534-4681 |
IngestDate | Thu Aug 21 18:35:51 EDT 2025 Fri Jul 11 07:26:41 EDT 2025 Sat Aug 16 19:51:30 EDT 2025 Thu Apr 24 02:14:19 EDT 2025 Tue Jul 01 05:12:30 EDT 2025 Thu Apr 10 07:49:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Minimally invasive surgery Prior abdominal surgery Endometrial cancer Anemia Uterine size Chemoresistance Hysterectomy Conversion Blood transfusion Open surgery Risk factors |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c426t-5cf579b8653f92c4ebd6b4144310dce41262fe677eb920ea9a3ec9d6811d5eb53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1245/s10434-025-16949-y |
PMID | 39982547 |
PQID | 3189962734 |
PQPubID | 32486 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11976340 proquest_miscellaneous_3169181395 proquest_journals_3189962734 pubmed_primary_39982547 crossref_primary_10_1245_s10434_025_16949_y springer_journals_10_1245_s10434_025_16949_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-05-01 |
PublicationDateYYYYMMDD | 2025-05-01 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: United States – name: New York |
PublicationTitle | Annals of surgical oncology |
PublicationTitleAbbrev | Ann Surg Oncol |
PublicationTitleAlternate | Ann Surg Oncol |
PublicationYear | 2025 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | G Scaletta (16949_CR3) 2020; 46 N Jones (16949_CR7) 2014; 134 NR Kim (16949_CR11) 2022; 166 K Matsuo (16949_CR10) 2016; 26 A Papadia (16949_CR14) 2020; 301 SI Kim (16949_CR13) 2021; 18 C Uwins (16949_CR2) 2021; 33 M Janda (16949_CR5) 2017; 317 JL Walker (16949_CR6) 2009; 27 SB Dewdney (16949_CR8) 2018; 148 G Scaletta (16949_CR12) 2020; 46 MC Cusimano (16949_CR4) 2019; 221 16949_CR1 T Tanaka (16949_CR15) 2020; 25 C Lönnerfors (16949_CR9) 2013; 78 |
References_xml | – volume: 317 start-page: 1224 issue: 12 year: 2017 ident: 16949_CR5 publication-title: JAMA. doi: 10.1001/jama.2017.2068 – volume: 221 start-page: 410 issue: 5 year: 2019 ident: 16949_CR4 publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2019.05.004 – volume: 46 start-page: 782 issue: 5 year: 2020 ident: 16949_CR12 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2019.11.519 – volume: 166 start-page: 236 issue: 2 year: 2022 ident: 16949_CR11 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2022.06.004 – volume: 46 start-page: 782 issue: 5 year: 2020 ident: 16949_CR3 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2019.11.519 – volume: 301 start-page: 585 issue: 2 year: 2020 ident: 16949_CR14 publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-019-05393-5 – volume: 33 start-page: e372 issue: 9 year: 2021 ident: 16949_CR2 publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2021.05.001 – volume: 18 start-page: 1153 issue: 5 year: 2021 ident: 16949_CR13 publication-title: Int J Med Sci doi: 10.7150/ijms.52293 – volume: 27 start-page: 5331 issue: 32 year: 2009 ident: 16949_CR6 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.3248 – volume: 25 start-page: 1985 issue: 11 year: 2020 ident: 16949_CR15 publication-title: Int J Clin Oncol doi: 10.1007/s10147-020-01744-4 – volume: 78 start-page: 12 issue: 1 year: 2013 ident: 16949_CR9 publication-title: Ceska Gynekol – volume: 148 start-page: 439 issue: 3 year: 2018 ident: 16949_CR8 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2018.01.021 – volume: 26 start-page: 290 issue: 2 year: 2016 ident: 16949_CR10 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000594 – volume: 134 start-page: 238 issue: 2 year: 2014 ident: 16949_CR7 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.06.008 – ident: 16949_CR1 |
SSID | ssj0017305 |
Score | 2.4629333 |
Snippet | Background
Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have... Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC... BackgroundEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3458 |
SubjectTerms | Adult Aged Body mass index Body weight Carcinoma Clinical outcomes Conversion to Open Surgery - statistics & numerical data Decision making Demography Endometrial cancer Endometrial Neoplasms - pathology Endometrial Neoplasms - surgery Endometrium Female Follow-Up Studies Gynecologic Oncology Gynecology Histology Humans Hysterectomy Invasiveness Laparoscopy Laparoscopy - methods Malignancy Medicine Medicine & Public Health Middle Aged Minimally invasive surgery Minimally Invasive Surgical Procedures - methods Obesity Obstetrics Oncology Patients Prognosis Registries - statistics & numerical data Statistical analysis Surgery Surgical Oncology Surgical site infections Tumors Underweight Uterine cancer Uterus |
Title | Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Patients with Endometrial Cancer in the SGO Clinical Outcomes Registry |
URI | https://link.springer.com/article/10.1245/s10434-025-16949-y https://www.ncbi.nlm.nih.gov/pubmed/39982547 https://www.proquest.com/docview/3189962734 https://www.proquest.com/docview/3169181395 https://pubmed.ncbi.nlm.nih.gov/PMC11976340 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD6CTUK8IO5kjOkg8QaRGt8SP2ZRuwHqhhiVxlNkJ-6o1KWol0n9HfxhfJy0UAYPvCQPtpzE37HzHZ8bwJukzirBbBqPVaVjkfVMrLnVceYEr7TSWR2KTQzP1OlIfLiUl12aHIqF-d1-z4SkEDfBRUxFVxOlhY7Xd2FfJjylMg2FKrYWAy-pMlg2lV_ATMkuQObvY-z-hG4xy9sOkn9YScPPZ_AQHnSsEfMW5kdwxzWP4d6ws4s_gR8FOY-Hky-kgBEcTprJtZlO1_i-uTHkoo4Xq3nY5TDv0oi7BS5nSB4loc3N15hT6SH81OZaXSAd0mK_qWfXLlT3wIJkZI6TBj1vxIuTc-zyik7xfLX0wuvH_OyuQgW5pzAa9L8Up3FXbiH2aKllLKuxTLXNlORjzSrhbK2s8AqXZ4B-JkTCFBs7labOatZzRhvuKl2rLElq6azkz2CvmTXuBaDK6sxZTwWtsYLXlTHceL2RmUS5mqdVBG83819-b7NqlKSNeLTKFq3So1UGtMp1BIcbiMpuhS1KvxdpKhzERQSvt81-bZDBwzRutqI-SnsGw7WM4HmL6PZxnpiRcpxGkO1gve1Aebd3W5rJt5B_myyvioteBO82YvHrvf79GQf_1_0l3GckssG58hD2lvOVe-UJ0NIewX4-OD4-o_vJ14_9o7AS_HXE8p-gzwQf |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD6CIcFeJu4LDDhIvEGkJr7EfqyqjQ7WDbFV2ltkJy6r1KVTmyL1d-wPc-wkRWXwwLMtJ_F3jv2dnBvAh6RUBU9tFk9koWOueibWzOpYOc4KLbUqQ7OJ0akcjvmXS3HZJoUtu2j3ziUZTupQAYELn-zGGY99-9VEaq7j9X14QGRAeVkep_2N74BkVgQfpyRVTqVoU2X-vsb2dXSHY94NlfzDXxquoaPHsNfyR-w3gD-Be656Cg9HrYf8GdwOfBh5-AeGPnUER9Nqem1mszUeVz-ND1bH89UinHfYbwuKuyXWc_SxJWHMLdbY902I8FtTdXWJ_nctHlbl_NqFPh848NKywGmFxCDx_PMZthVGZ3i2qmlHac3v7kfoJfccxkeHF4Nh3DZeiAk3WceimIhMWyUFm-i04M6W0nIyvYgL0k7wJJXpxMksc1anPWe0Ya7QpVRJUgpnBXsBO9W8cvuAUpXKWSKF1ljOysIYZsiCTE0iXcmyIoKP3f7nN019jdzbJYRW3qCVE1p5QCtfR3DQQZS3urbM6VTSvoUQ4xG83wyTlnjXh6ncfOXnSE1chmkRwcsG0c3jiKJ5MzmLQG1hvZngK3Bvj1TTq1CJ2_tgJeO9CD51YvH7vf79Ga_-b_o7eDS8GJ3kJ8enX1_DburFN4RcHsBOvVi5N0SLavs2aMEvf5MHPQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_BkCZeEN8LDDASbxDRxB-xH6uwsgHdJsakvUV27EClzp3aFKl_B_8wPictlMEDz7acxL87-y539zuAV5mVNctNkTaiVimTA50qalQqHaO1Ekra2GxifCwOz9mHC37xWxV_zHZfhyS7mgZkafLt2yvbdGwIjGPhG6MsxVasmVBMpaubcCt4Khm6X6UoN3GEIL88xjtFUOtc8L5s5u9rbF9N1-zN62mTf8RO45U0ugt3eluSDDvw78EN5-_D7riPlj-AHyWmlMf_YQTLSMh44ieXejpdkSP_XWPiOjlbzuPZR4Y9ubhbkHZGMM8kjrn5igyxIRE57RhYFwR_3ZIDb2eXLvb8ICVKzpxMPAnWJDl7f0J6ttEpOVm2YXfDmp_d19hX7iGcjw6-lIdp34QhDRiKNuV1wwtlpOC0UXnNnLHCsOCGBbsw7ATLcpE3ThSFMyofOK00dbWyQmaZ5c5w-gh2_My7PSBCWulMMBCNNozaWmuqgzeZ60w4S4s6gdfr_a-uOq6NCn2UgFbVoVUFtKqIVrVKYH8NUdXr3aIKJ5TCdkKUJfByMxw0BsMg2rvZEucIFewaqngCjztEN48L5hq6zEUCcgvrzQRk494e8ZNvkZUb47GCskECb9Zi8eu9_v0ZT_5v-gvYPX03qj4dHX98CrdzlN6YfbkPO-186Z4FC6k1z6MS_AQW6Qtj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conversion+from+Minimally+Invasive+Surgical+Approaches+to+Open+Surgery+Among+Patients+with+Endometrial+Cancer+in+the+SGO+Clinical+Outcomes+Registry&rft.jtitle=Annals+of+surgical+oncology&rft.date=2025-05-01&rft.pub=Springer+Nature+B.V&rft.issn=1068-9265&rft.eissn=1534-4681&rft.volume=32&rft.issue=5&rft.spage=3458&rft.epage=3464&rft_id=info:doi/10.1245%2Fs10434-025-16949-y&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon |